Walwyn, David Richard
(Routledge, 2013)
Registered in 2001, tenofovir disoproxil fumarate (TDF) has quickly become a mainstay of first line regimens
for the treatment of HIV. Initially only available in developed countries at a cost of US$5 000 per person per ...